Page URL:

Largest ever release of child cancer genome data boosts research

6 June 2012
Appeared in BioNews 659

A wealth of whole genome data – or the entire genetic code – from children with cancer has been released by scientists in the US. The researchers claim the database more than doubles the volume of highly detailed, whole genome data available worldwide.

The data has been generated as part of the three-year Paediatric Cancer Genome Project (PCGP), a collaboration between St Jude Children's Research Hospital in Memphis, Tennessee and Washington University. So far the project has sequenced the DNA of 260 children with cancer, and by the year end that number is expected to reach 600.

Two samples have been sequenced from each patient: one from the tumour; the other from healthy tissue. By looking for differences between the healthy cells and the cancer cells, the scientists hope to identify the mutations that cause the cancers.

The project, which cost an estimated $65 million, is the first privately funded study of its kind to make its data freely available.

Dr William Evans, CEO and director of St Jude Children's Research Hospital called the PCGP 'a one-of-a-kind effort, so the information has the potential to accelerate disease research worldwide'.

Improvements in the early detection of childhood cancers have raised survival rates over the past two decades, but treatment continues to rely on conventional approaches which often have severe side effects. By identifying the mutations that cause the cancer, scientists hope it will be possible to target drugs directly to the root of the problem.

Unlike many studies which only look at certain regions of the genome, the PCGP researchers have analysed the entire sequence, including DNA that does not code for proteins. This allows the researchers to identify more unusual, 'cryptic' changes which would not otherwise have been found.

The project has already yielded results which are published in the journal Nature Genetics. An aggressive form of acute lymphoblastic leukemia (ALL) was shown to be genetically closer to acute myeloid leukemia (AML) rather than other lymphoblastic leukemias. Treatments for ALL and AML are very different, so treating this form of ALL with AML drugs may be an approach worth investigating.

Another surprising finding was that cancer of the retina (a part of the eye) could be traced to a single gene, SYK. Expression of SYK was altered in every retinal tumour analysed, and an existing cancer drug targeting the gene shows promise in early lab tests, researchers say.

Speaking to Time magazine, Dr James Downing, scientific director at St Jude, said: 'There is a wealth of information that we are generating and it will take years to extract all the valuable information. But we need to start by getting it out into the hands of everybody in the scientific field – not only those in cancer research – so they can used it both as a reference and as a discovery tool, and find new things that we have yet to find'.

23 November 2015 - by Dr Molly Godfrey 
A substantial proportion of childhood cancers are caused by mutations in genes that are known to cause cancer in adults, scientists have found...
1 December 2014 - by Dr Anna Cauldwell 
Genetics researchers in the US have identified mutations that significantly increase the likelihood that an individual will go on to develop blood cancer...
16 September 2013 - by Siobhan Chan 
One comprehensive genetic database is needed for the prevention of deaths from cardiac disease to be a reality, says a cardiology expert...
22 July 2013 - by Maren Urner 
The world's largest database of cancer-related genetic variations to date has been made available by the National Cancer Institute (NCI), US...
7 May 2013 - by Suzanne Elvidge 
Genetic analysis of tumours provides the key to treating them effectively, according to two studies carried out by The Cancer Genome Atlas (TCGA)....
2 April 2012 - by Cait McDonagh 
The world's largest database of medical information has opened online, allowing researchers around the world to access its contents. The UK Biobank holds anonymous information from more than 500,000 British people, making it a 'globally unique resource' according to England's chief medical officer, Dame Sally Davies...
5 March 2012 - by Ruth Saunders 
A free information resource detailing numerous disease-specific genetic tests that are now available was launched last week by the US National Institutes of Health (NIH)...
28 November 2011 - by Dr Rosie Morley 
An initiative has been launched to collect genetic data from NHS cancer patients in the hope of developing new, personalised treatments....
22 June 2009 - by Lorna Stewart 
Neuroblastoma, a form of paediatric cancer which affects the nervous system, may be caused by copy number variations (CNVs) in genes which control nervous system development. The research, published last week in Nature, suggests a different genetic mechanism for cancers than was previously proposed. Dr John Maris who led the study at the University of Pennsylvania, Philadelphia, US, said 'We can infer that it's not just going to be true for neuroblastoma. My expectation is that there will be ...
17 September 2007 - by Ailsa Stevens 
Geneticists taking part in debate being held today at the British Society of Human Genetics (BSHG) annual conference in York will voice concerns over conflicts of interest emerging around the creation of human DNA databases. However, they will also highlight the importance of guaranteeing public confidence to...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.